A5016430670- Gastric Cancer Management and Outcomes
- Gastrointestinal Tumor Research and Treatment
- Metastasis and carcinoma case studies
- Bariatric Surgery and Outcomes
- Esophageal Cancer Research and Treatment
- Helicobacter pylori-related gastroenterology studies
- Body Contouring and Surgery
- Esophageal and GI Pathology
- Diet and metabolism studies
- Nutrition and Health in Aging
- Cholangiocarcinoma and Gallbladder Cancer Studies
University of Lausanne
2022-2025
Centre Hospitalier Universitaire de Bordeaux
2025
Université de Bordeaux
2025
University Hospital of Lausanne
2022-2023
Objective: To assess the outcomes of Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) in patients with prior fundoplication. Summary Background Data: Obesity gastroesophageal reflux disease (GERD) often coexist, posing clinical challenges. Fundoplication is standard treatment for GERD refractory to medical therapy. Managing obesity after fundoplication complex while RYGB preferred addressing both GERD, its use post-fundoplication requires further evaluation. Methods: Retrospective...
Perioperative chemotherapy combined with surgical resection represent the gold standard in treatment of locally advanced gastric cancer. The Mandard tumor regression score (TRG) is widely used to evaluate pathological response neoadjuvant treatment. aim this study was assess prognostic value TRG terms overall survival (OS) and disease-free (DFS).
Abstract Background According to current international guidelines, stage cT2N0M0 gastric adenocarcinoma warrants preoperative chemotherapy followed by surgery. However, upfront surgery is often preferred in clinical practice, depending on patient status and local treatment preferences. Objective The aim of the present study was assess impact neoadjuvant overall survival (OS) disease-free (DFS) patients. Methods A retrospective analysis performed among 32 centers, including patients operated...
Although Roux-en-Y gastric bypass (RYGB) is widely performed worldwide, its efficacy in patients with a body mass index (BMI) greater than 50 kg/m2 remains controversial. The aim of the present paper was to assess long-term (10 years or more) weight loss and metabolic results RYGB superobesity (SO; BMI > kg/m2), compared morbid obesity (MO; 35-50 kg/m2).This study involved retrospective analysis prospectively followed cohort adult operated on for primary between 1999 2008. Long-term...
Abstract Background and aim According to current international guidelines, the optimal treatment of stage cT2N0M0 gastric adenocarcinoma consists preoperative chemotherapy followed by surgery. Surgery first may be suggested in selected patients, especially if considered unfit for chemotherapy. The present study was assess patients treated with surgery (S) had inferior overall disease-free survival compared those neoadjuvant (CS). Methods A retrospective analysis performed among 32 centers,...